Cardiac Marker Rapid Test Kit

A rapid diagnostic test for detecting cardiac markers to assess heart disease and cardiac events. This test provides quick results for emergency cardiac screening.

Rapid immunoassay test for detection of cardiac biomarkers indicating myocardial injury. Supports acute coronary syndrome diagnosis and cardiac event assessment.

High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.

Rapid immunoassay test kit for cardiac biomarker detection, enabling point-of-care diagnosis of acute myocardial infarction and heart failure. Single-use disposable format delivers results within 10-15 minutes, supporting emergency department triage and risk stratification in acute cardiac care settings.

Rapid diagnostic test for cardiac markers including myocardial infarction indicators. Enables quick assessment of cardiac events in clinical laboratories.

In vitro diagnostic reagent for cardiac biomarker detection. Enables rapid assessment of cardiac function and myocardial injury.

In vitro diagnostic test for detection of cardiac-related biomarkers indicating myocardial injury or cardiac function status. Supports cardiovascular risk assessment and acute coronary syndrome evaluation.

A diagnostic test for cardiac risk markers assessment in cardiovascular health evaluation. Detects biomarkers indicative of potential cardiac conditions.

Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.

IVD kit for detection and quantification of troponin and other cardiac markers. Used for diagnosis and monitoring of myocardial infarction in acute care settings.

A rapid immunochromatographic assay using colloidal gold-labeled fixed-phase technology to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, or plasma. The triple simultaneous detection provides greater clinical diagnostic significance for cardiac assessment.

Point-of-care immunoassay kits for rapid detection of infectious diseases and biomarkers. Provides results within minutes for urgent clinical decision-making.